Darío Antolín-Amérigo2 Department of Allergy, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain
,
Javier Domínguez-Ortega3 Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ);4 CIBER de Enfermedades Respiratorias, CIBERES, Madrid, Spain
&
Santiago Quirce3 Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ);4 CIBER de Enfermedades Respiratorias, CIBERES, Madrid, Spain
ChapmanRWMinnicozziMCellyCSA novel, orally active CXCR1/2 receptor antagonist, SCH527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammationJournal of Pharmacology and Experimental Therapeutics2007322248649317496165
NairPGagaMZervasESafety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trialClin Exp Allergy20124271097110322702508
O’ByrnePMMetevHPuuMEfficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trialLancet Respir Med201641079780627574788
WenzelSEBarnesPJBleeckerERA Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-α Blockade in Severe Persistent AsthmaAm J Respir Crit Care Med2009179754955819136369
ChuDKAl-GarawiALlop-GuevaraATherapeutic potential of anti-IL-6 therapies for granulocytic airway inflammation in asthmaAllergy, Asthma & Clinical Immunology201511114
BusseWWHolgateSKerwinERandomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe AsthmaAm J Respir Crit Care Med2013188111294130224200404
MercadoNHakimAKobayashiYRestoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthmaPLoS One201277e4158222911818
Marks-KonczalikJCostaMRobertsonJA post-hoc subgroup analysis of data from a six month clinical trial comparing the efficacy and safety of losmapimod in moderate-severe COPD patients with ≤2% and >2% blood eosinophilsRespir Med2015109786086926033641
BardinPKanniessFGauvreauGBredenbrökerDRabeKFRoflumilast for asthma: Efficacy findings in mechanism of action studiesPulm Pharmacol Ther201535Suppl(Suppl)S4S1026296794
GibsonPGYangIAUphamJWEffect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trialLancet20173901009565966828687413
ManeechotesuwanKKasetsinsombatKWamanuttajindaVWong-kajornsilpABarnesPJStatins enhance the effects of corticosteroids on the balance between regulatory T cells and Th17 cellsClin Exp Allergy201343221222223331562